Advertisement

Topics

Merck pays PDL $19.5mm to settle Keytruda patent lawsuit and gain patent rights

15:40 EDT 15 May 2017 | Elsevier Business Intelligence

Merck & Co. Inc. and PDL Biopharma Inc. settled a patent infringement lawsuit brought against Merck in 2015 in which PDL clai...

Original Article: Merck pays PDL $19.5mm to settle Keytruda patent lawsuit and gain patent rights

NEXT ARTICLE

More From BioPortfolio on "Merck pays PDL $19.5mm to settle Keytruda patent lawsuit and gain patent rights"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...